10x Genomics, Inc. is trading 6.8% down at $31.24 today as the stock undergoes mean reversion and profit-taking following a significant multi-day advance.
- The decline follows a sharp 33% rebound between May 27 and June 4, which occurred without major company-specific catalysts.
- Today's move appears to be technically driven, exacerbated by broader weakness across the technology sector rather than new fundamental developments.
- Shares are retreating toward a mean level after the recent rally saw the stock price surge from recent lows in late May.